Claret Medical launches a pivotal U.S. trial for its Sentinel cerebral protection system, which is designed to guard against stroke during transcatheter aortic valve implantation.
Claret Medical said today that the 1st patient has been treated in a U.S. pivotal trial of its Sentinel cerebral protection system, which is designed to guard against stroke during transcatheter aortic valve implantation.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1vHF92i
Cap comentari:
Publica un comentari a l'entrada